NCT07317778 2026-01-05
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
British Columbia Cancer Agency
Fudan University
Fondazione Policlinico Universitario Agostino Gemelli IRCCS